Cryptosporidium parvum, a microscopic protozoan parasite belonging to the Apicomplexa phylum, has garnered attention for its impact on waterborne diseases and gastrointestinal infections. The activation mechanisms of Cryptosporidium parvum are complex and multifaceted, involving various environmental factors and host interactions. These activators play a critical role in the parasite's life cycle and pathogenicity. One key activator for Cryptosporidium parvum is the host's immune status. When an individual's immune system is compromised, either due to a weakened immune response or an immunosuppressive condition, it provides an environment in which the parasite can thrive and replicate. Additionally, host factors such as age, nutrition, and genetics can influence susceptibility to infection, acting as activators by either facilitating or hindering the parasite's establishment within the host.
Furthermore, environmental factors also serve as significant activators for Cryptosporidium parvum. This parasite is highly resilient and can persist in a variety of settings, including water sources. Contaminated water serves as a crucial activator for the transmission of Cryptosporidium parvum. Temperature and humidity can also impact the parasite's survival and transmission, making climatic conditions additional activators. In conclusion, Cryptosporidium parvum activators encompass a broad spectrum of host and environmental factors that influence the parasite's life cycle and pathogenicity, contributing to the challenges in managing infections caused by this protozoan parasite. Understanding these activators is crucial for public health efforts aimed at reducing the prevalence of Cryptosporidium parvum-related illnesses.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporin A is an immunosuppressant, and its use might indirectly activate Cryptosporidium parvum by suppressing the host's immune response, allowing the parasite to proliferate. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin, a PI3-kinase inhibitor, may indirectly activate Cryptosporidium parvum by modulating signaling pathways involved in host-parasite interactions. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580, a p38 MAPK inhibitor, could indirectly activate Cryptosporidium parvum by altering host cell responses and signaling pathways. | ||||||
JAK Inhibitor I | 457081-03-7 | sc-204021 sc-204021A | 500 µg 1 mg | $156.00 $339.00 | 59 | |
This Janus kinase inhibitor may indirectly activate Cryptosporidium parvum by modulating signaling pathways in the host, potentially affecting the parasite's activation. | ||||||
N-Acetyl-L-cysteine | 616-91-1 | sc-202232 sc-202232A sc-202232C sc-202232B | 5 g 25 g 1 kg 100 g | $34.00 $74.00 $270.00 $114.00 | 34 | |
NAC, an antioxidant, may activate Cryptosporidium parvum indirectly by reducing oxidative stress and altering host-parasite interactions. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $28.00 $53.00 | 37 | |
2-APB, an IP3 receptor inhibitor, might indirectly activate Cryptosporidium parvum by interfering with host cell calcium signaling, which the parasite relies on. | ||||||
Z-VAD-FMK | 187389-52-2 | sc-3067 | 500 µg | $75.00 | 256 | |
Z-VAD-FMK, a caspase inhibitor, may indirectly activate Cryptosporidium parvum by modulating host cell apoptosis, which can be exploited by the parasite during infection. | ||||||